New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]
The Departments of Labor (DOL), Health and Human Services (HHS), and the Treasury announced on May 15, 2025 that they will not enforce the portions of the 2024 final rule implementing the nonquantitative treatment limitation (NQTL) comparative analyses requirements under the Mental Health Parity […]